Compare Ascendis Pharma A/S (ASND) vs NetApp Inc. (NTAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs NetApp Inc. — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while NetApp Inc. trades at $199.49 (market cap $38.95B). The key difference: NetApp Inc. is far larger — about 2.3× Ascendis Pharma A/S's market cap, and NetApp Inc. pays a 1.05% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | NTAP | |
|---|---|---|
Market Cap | $16.67B | $38.95B |
Sector | Health | Technology |
52-Week High | $277.18 | $198.72 |
52-Week Low | $189.74 | $94.11 |
Enterprise Value | $17.04B | $38.10B |
Dividend Yield | — | 1.05% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About NetApp Inc.
NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →
